Drug Device Combination Products

Drug Device Combination Products

Global Drug Device Combination Products Market to Reach US$158.7 Billion by 2030

The global market for Drug Device Combination Products estimated at US$114.8 Billion in the year 2023, is expected to reach US$158.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the end of the analysis period. Growth in the Inhalers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$30.6 Billion While China is Forecast to Grow at 8.3% CAGR

The Drug Device Combination Products market in the U.S. is estimated at US$30.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$36.2 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Drug Device Combination Products Market - Key Trends & Drivers Summarized

What Are Drug Device Combination Products And Why Are They Important?

Drug device combination products are innovative therapeutic solutions that combine drugs, devices, and sometimes biologics to improve the efficacy, safety, and convenience of treatment for various medical conditions. These products are increasingly gaining importance in the healthcare industry as they offer enhanced treatment outcomes through synergistic effects, providing targeted drug delivery, controlled release, and reduced side effects. Common examples include drug-eluting stents, prefilled syringes, inhalers, transdermal patches, and implantable devices with drug coatings. The integration of drugs and devices is particularly valuable in chronic disease management, oncology, and cardiovascular treatments, where precision, control, and patient adherence are critical. As the demand for personalized and effective treatment options grows, drug device combination products are becoming an essential component of modern healthcare.

How Are Technological Advancements Driving The Drug Device Combination Products Market?

Technological advancements are significantly driving the growth and development of the drug device combination products market. Innovations in drug delivery systems, such as microneedle patches, smart inhalers, and bioresorbable stents, are enhancing patient compliance and therapeutic effectiveness. The incorporation of digital health technologies, including sensors and wireless connectivity, is enabling real-time monitoring of patient adherence and drug delivery, providing valuable data to healthcare providers for optimizing treatment plans. Additionally, the development of novel materials, such as biocompatible polymers and hydrogels, is improving the safety and efficacy of implantable devices, reducing the risk of adverse reactions. The use of 3D printing technology in manufacturing combination products is also allowing for greater customization and precision, catering to the specific needs of individual patients. These technological advancements are transforming the market landscape by offering innovative solutions that address unmet clinical needs.

How Are Regulatory Pathways And Market Dynamics Impacting Drug Device Combination Products?

The regulatory landscape for drug device combination products is complex, as these products must meet the standards of both drug and device regulations. Regulatory bodies such as the FDA and EMA are increasingly developing specific guidelines to streamline the approval process for combination products, ensuring safety and efficacy while reducing time to market. These regulatory frameworks are encouraging innovation by providing clearer pathways for the development and commercialization of combination products. Market dynamics, such as the rising prevalence of chronic diseases, the aging population, and the demand for minimally invasive treatments, are further driving the adoption of drug device combination products. The increasing focus on patient-centric care and the need for cost-effective healthcare solutions are also promoting the use of these products, as they offer improved treatment outcomes and reduced hospital stays.

What Factors Are Driving The Growth Of The Drug Device Combination Products Market?

The growth in the drug device combination products market is driven by several factors, including technological advancements, favorable regulatory environments, and the rising prevalence of chronic diseases. A key driver is the increasing demand for minimally invasive treatments that offer better patient compliance and outcomes. The growing adoption of digital health technologies and smart drug delivery systems is also enhancing the effectiveness and convenience of combination products, making them more attractive to both healthcare providers and patients. Additionally, the expansion of healthcare infrastructure in emerging markets and the increasing focus on personalized medicine are supporting the development and adoption of these products. Strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions are further propelling innovation and market growth. These factors, coupled with the continuous advancement of materials science and drug formulation technologies, are driving the global market for drug device combination products forward.

Select Competitors (Total 46 Featured) -
  • Abbott Laboratories
  • Alcon, a Novartis Company
  • Allergan PLC
  • Arrow International, Inc.
  • Bausch & Lomb, Inc.
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • CareFusion Corporation
  • Ethicon US LLC
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mylan NV
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Drug Device Combination Products – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Minimally Invasive Treatment Solutions
Increasing Adoption of Drug-Eluting Stents and Implantable Devices
Technological Advancements in Drug Delivery Mechanisms for Enhanced Efficacy
Growing Focus on Patient-Centric and Personalized Healthcare Solutions
Expansion of Applications for Combination Products in Chronic Disease Management
Impact of Regulatory Approvals and Fast-Track Designations on Market Growth
Increasing Collaborations Between Pharmaceutical and Medical Device Companies
Development of Smart Drug Device Combinations with Digital Health Integration
Rising Demand for Biodegradable and Implantable Drug Delivery Systems
Impact of Aging Population and Growing Burden of Chronic Diseases
Growing Investments in R&D for Novel Combination Products
Emerging Opportunities in Emerging Markets for Drug Device Combinations
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Drug Device Combination Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Drug Device Combination Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Transdermal Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Transdermal Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Prefilled Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Prefilled Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Photodynamic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Photodynamic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Nebulizers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Nebulizers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Antimicrobial Wound Dressings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Antimicrobial Wound Dressings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Home Care Setting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Home Care Setting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 59: China Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Drug Device Combination Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 74: France Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: France Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: France 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 77: France Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Germany Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Germany 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 83: Germany Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Germany Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Germany 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 86: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Italy Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Italy 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 89: Italy Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Italy Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Italy 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 92: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: UK Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: UK 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 95: UK Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: UK Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: UK 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 98: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Spain Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Spain 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 101: Spain Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Spain Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Spain 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 104: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Russia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Russia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 107: Russia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Russia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Russia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Rest of Europe Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Rest of Europe 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Rest of Europe Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Rest of Europe 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 117: Asia-Pacific Historic Review for Drug Device Combination Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 125: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Australia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Australia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 128: Australia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Australia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Australia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 131: India Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: India Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: India 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 134: India Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: India Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: India 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 137: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: South Korea Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: South Korea 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 140: South Korea Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: South Korea Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: South Korea 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of Asia-Pacific Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 149: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 150: Latin America Historic Review for Drug Device Combination Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Latin America 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 152: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 155: Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 158: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Argentina Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Argentina 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 161: Argentina Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Argentina Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Argentina 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 164: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Brazil Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Brazil 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 167: Brazil Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Brazil Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Brazil 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 170: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: Mexico Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: Mexico 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 173: Mexico Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: Mexico Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: Mexico 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: Rest of Latin America Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Latin America Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Latin America 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 182: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 183: Middle East Historic Review for Drug Device Combination Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Middle East 16-Year Perspective for Drug Device Combination Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 185: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 188: Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 191: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Iran Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Iran 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 194: Iran Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Iran Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Iran 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 197: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Israel Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Israel 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 200: Israel Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Israel Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Israel 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Saudi Arabia Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Saudi Arabia Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Saudi Arabia 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 209: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: UAE Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: UAE 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 212: UAE Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: UAE Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: UAE 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Rest of Middle East Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Rest of Middle East Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Rest of Middle East 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Drug Device Combination Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 221: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Africa Historic Review for Drug Device Combination Products by Product - Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Africa 16-Year Perspective for Drug Device Combination Products by Product - Percentage Breakdown of Value Sales for Transdermal Patches, Inhalers, Drug Eluting Stents, Prefilled Syringes, Photodynamic Therapy, Nebulizers, Antimicrobial Wound Dressings and Other Products for the Years 2014, 2024 & 2030
TABLE 224: Africa Recent Past, Current & Future Analysis for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Africa Historic Review for Drug Device Combination Products by End-Use - Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Africa 16-Year Perspective for Drug Device Combination Products by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Home Care Setting, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings